Literature DB >> 1360657

Studies on the interaction between formoterol and salmeterol in guinea-pig trachea in vitro.

A B Jeppsson1, B L Källström, B Waldeck.   

Abstract

The actions of and interaction between formoterol and salmeterol were studied on guinea-pig trachea in vitro. Tracheal strip preparations were contracted by 1 mumol/l carbachol giving a near maximal contraction. Salmeterol in concentrations from 0.1 to 3 mumol/l relaxed the tracheal smooth muscle by about 30 per cent of the maximum relaxation produced by theophylline. Formoterol caused a concentration-dependent and almost complete relaxation with a pD2 of 8.56. In the presence of salmeterol there was a rightward shift of the concentration-response curve for formoterol. The pA2 for salmeterol was estimated to 7.42. Similar experiments with isoprenaline indicated that salmeterol has a low affinity for beta 1-adrenoceptors. Formoterol and salmeterol both inhibited in a concentration-dependent manner the contractions evoked by stimulation of the vagus nerve in a tracheal tube preparation. The degree of inhibition decreased with increasing stimulation frequency. Complete inhibition was attained with salmeterol, but not with formoterol, at the highest frequency employed (45 Hz). The inhibiting effect of 10 mumol/l salmeterol was not blocked by 10 mumol/l sotalol, a beta-adrenoceptor antagonist. It is concluded that salmeterol, in comparison to formoterol, is a partial beta 2-adrenoceptor agonist and has, at high concentrations, an additional unspecific inhibitory action.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360657     DOI: 10.1111/j.1600-0773.1992.tb00982.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  8 in total

1.  Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.

Authors:  James G Ryall; Martin N Sillence; Gordon S Lynch
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

Review 2.  Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.

Authors:  A Lindén; K F Rabe; C G Löfdahl
Journal:  Lung       Date:  1996       Impact factor: 2.584

3.  Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.

Authors:  A Lindén; A Bergendal; A Ullman; B E Skoogh; C G Löfdahl
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

4.  Relaxation kinetics of formoterol and salmeterol in the guinea pig trachea in vitro.

Authors:  P Anderson; J Lötvall; A Lindén
Journal:  Lung       Date:  1996       Impact factor: 2.584

5.  The interaction between salmeterol and beta 2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro.

Authors:  B L Källström; J Sjöberg; B Waldeck
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

6.  Different effects of salmeterol, formoterol and salbutamol on cholinergic responses in the ferret trachea.

Authors:  A Bergendal; A Lindén; J Lötvall; B E Skoogh; C G Löfdahl
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

Review 7.  Comparison of the effectiveness and safety of formoterol versus salmeterol in the treatment of patients with asthma: A systematic review and meta-analysis.

Authors:  Ashraf Velayati; Seyed Alireza Hosseini; Ali Akbari Sari; Farideh Mohtasham; Mostafa Ghanei; Mohsen Yaghoubi; Reza Majdzadeh
Journal:  J Res Med Sci       Date:  2015-05       Impact factor: 1.852

8.  Treatment with budesonide/formoterol pressurized metered-dose inhaler in patients with asthma: a focus on patient-reported outcomes.

Authors:  Richard D O'Connor
Journal:  Patient Relat Outcome Meas       Date:  2011-01-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.